The present invention relates to a synthetic peptide comprising the following elements from the N-terminus to the C-terminus: a) a first cell-penetrating peptide or functional fragments or derivatives, or biologically active variants thereof and b) a second peptide with agonist activity of OR1 and OR2 receptors or functional fragments or derivatives, or biologically active variants thereof.
Artificial protein and its applications / Alessandro Silvani; Giuseppe Plazzi; Giorgio Medici; Stefania Trazzi; Elisabetta Ciani; Gabriele Matteoli; Sara Alvente; Viviana Lo Martire; Stefano Bastianini; Chiara Berteotti; Giovanna Zoccoli. - (2022).
Artificial protein and its applications
Alessandro Silvani;Giuseppe Plazzi;Giorgio Medici;Stefania Trazzi;Elisabetta Ciani;Gabriele Matteoli;Sara Alvente;Viviana Lo Martire;Stefano Bastianini;Chiara Berteotti;Giovanna Zoccoli
2022
Abstract
The present invention relates to a synthetic peptide comprising the following elements from the N-terminus to the C-terminus: a) a first cell-penetrating peptide or functional fragments or derivatives, or biologically active variants thereof and b) a second peptide with agonist activity of OR1 and OR2 receptors or functional fragments or derivatives, or biologically active variants thereof.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
